FGF18 accelerates osteoblast differentiation by upregulating Bmp2 expression

Congenital Anomalies

Volumn 53, Issue 2, 2013, Pages 83-88

  Nagayama, Tomoko ^a   Okuhara, Shigeru ^a   Ota, Masato S ^a   Tachikawa, Noriko ^a   Kasugai, Shohei ^a   Iseki, Sachiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein 2; ex utero surgery; Fibroblast growth factor 18; Osteoblast differentiation; Skull bones

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 18;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; MESENCHYME; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; OSTEOBLASTS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84878976449     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/cga.12012     Document Type: Article

References (18)

1. Bénazet JD, Zeller R. 2009. Vertebrate limb development: moving from classical morphogen gradients to an integrated 4-dimentional patterning system. Cold Spring Harb Perspect Biol 1:a001339.
2. Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L etal. 1998. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev 77:19-30.
3. Fujioka-Kobayashi M, Ota MS, Shimoda A etal. 2012. Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. Biomaterials 33:7613-7620.
4. Groppe J, Greenwald J, Wiater E etal. 2002. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420:636-642.
5. Harada M, Murakami H, Okawa A etal. 2009. FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat Genet 41:289-298.
6. Iseki S, Wilkie AO, Morriss-Kay GM. 1999. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126:5611-5620.
7. Itoh N, Ornitz DM. 2011. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149:121-130.
8. Kim HJ, Rice DP, Kettunen PJ, Thesleff I. 1998. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125:1241-1251.
9. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869.
10. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. 2002. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 3:1-20.
11. Miraoui H, Marie PJ. 2010. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal 3:re9.
12. Montero A, Okada Y, Tomita M etal. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093.
13. Morriss-Kay GM, Wilkie AO. 2005. Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 207:637-653.
14. Ohbayashi N, Shibayama M, Kurotaki Y etal. 2002. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-879.
15. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1365.
16. Valverde-Franco G, Liu H, Davidson D etal. 2004. Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum Mol Genet 13:271-284.
17. Wang Q, Green RP, Zhao G, Ornitz DM. 2001. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 128:3867-3876.
18. Wood HB, Ward SJ, Morriss-Kay GM. 1996. Effects of all-trans-retinoic acid on skeletal pattern, 5′HoxD gene expression, and RAR beta 2/beta 4 promoter activity in embryonic mouse limbs. Dev Genet 19:74-84.